This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cigna Combats Colorectal Cancer With Campaign Aimed At Two Million Individuals Due For Screening

More than one million people in the U.S. are survivors of colorectal cancer, thanks to better prevention, early detection and treatment improvements, according to the American Cancer Society. Nevertheless, colorectal cancer remains the third leading cause of cancer-related deaths in the U.S., and is expected to kill 50,830 Americans in 2013. 1

Cigna (NYSE:CI) has been working for the past eight years to turn the tide against colorectal cancer with its award-winning Colorectal Cancer Screening Program. The battle continues this year as the company rolls out an enhanced program in March that will reach two million people who are due for screening, through a combination of targeted online messages and direct mail. Cigna podcast on importance of colorectal cancer screening.

Approximately 300,000 newly eligible individuals covered by a Cigna medical plan who are 50 to 64 years of age, and whose claims data indicate they have not had a colorectal cancer screening, will receive information in the mail about appropriate colon cancer screening tests, including colonoscopy. In addition, they will be offered the opportunity to request the InSure® FIT™ screening kit, an easy and convenient at-home test that is sensitive at detecting abnormalities in the lower gastrointestinal tract. Cigna has made an arrangement with Quest Diagnostics (NYSE: DGX) to provide the test kit at no charge, and the laboratory processing fees are covered as a preventive benefit under most Cigna plans. Visit www.insuretest.com for more information about the test.

Eleven thousand Cigna customers who, based on Cigna claims data, completed either the at-home kit or a fecal occult blood test (FOBT) in the last three years and did not have a follow-up colonoscopy or sigmoidoscopy, have been selected to receive an InSure® FIT™ kit this year.

In addition, all Cigna customers who are age 50 to 64 will see a targeted message about colon cancer screening and the InSure® FIT™ kit whenever they logon to the company’s customer web portal, myCigna.com, between the last week of March and May 30. That means customers using the web portal for common online activities such as finding a doctor, refilling a prescription, taking a health assessment, checking on coverage or reviewing a claim will be exposed to this potentially life-saving message.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs